8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Jul 16, 2008)

Filed July 16, 2008For Securities:ABT

Summary

This 8-K filing from Abbott Laboratories, filed on July 16, 2008, announces the company's financial results for the second quarter of 2008. The report primarily serves to furnish a press release detailing these results. Investors should note that Abbott uses non-GAAP financial measures to provide a clearer view of ongoing business performance, adjusting for items such as acquisition-related costs and cost reduction initiatives. While the specific financial figures for Q2 2008 are not detailed within the 8-K itself but rather in the furnished press release (Exhibit 99.1), the filing signals that Abbott's management believes these adjusted metrics are valuable for investors to assess operational performance. Investors are advised to consider these non-GAAP measures alongside standard GAAP financial information.

Key Highlights

  • 1Abbott Laboratories announced its second quarter 2008 financial results on July 16, 2008.
  • 2The 8-K filing's primary purpose is to furnish the press release containing these results (Exhibit 99.1).
  • 3Abbott utilizes non-GAAP financial measures, such as net earnings and diluted EPS excluding specified items, in its reporting.
  • 4These non-GAAP measures are intended to provide investors with a better evaluation of ongoing business performance by excluding unusual or unpredictable factors.
  • 5Examples of items adjusted for include acquisition-related costs, cost reduction initiatives, acquired in-process R&D, and investment gains/losses.
  • 6Abbott's management uses these non-GAAP measures internally for performance monitoring.
  • 7Investors are cautioned to consider these non-GAAP measures in addition to, and not as a substitute for, GAAP financial measures.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce and furnish the press release detailing Abbott Laboratories' financial results for the second quarter of 2008.

No, the 8-K filing itself does not contain the detailed financial numbers. Instead, it refers to and furnishes Exhibit 99.1, which is the press release containing the specific Q2 2008 results and associated financial data.

Non-GAAP financial measures are financial metrics that exclude certain items from GAAP (Generally Accepted Accounting Principles) results. In this case, Abbott adjusts for items such as acquisition-related costs, cost reduction initiatives, acquired in-process research and development, and gains/losses on certain investments, to provide a view of ongoing business performance.

Abbott's management believes these non-GAAP measures offer useful insights by excluding unusual or unpredictable factors, allowing investors to better evaluate ongoing business performance and compare periods. However, Abbott cautions investors to consider these non-GAAP measures in conjunction with, and not as a replacement for, their GAAP-reported financial results.